Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam, Lacosamide, Ketamine vs Phenobarbital for Refractory SE
NCT02726867Phase 3Withdrawn
- Sponsor
- Mid-Atlantic Epilepsy and Sleep Center
- Start
- Feb 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levetiracetam, lacosamide, ketamine in status epilepticus (SE), sponsored by Mid-Atlantic Epilepsy and Sleep Center. Planned start Feb 2014; status: withdrawn.
02
Drugs
levetiracetamlacosamideketamine
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT02726867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726867.